米国のバスキュラーアクセスデバイス市場規模、シェア、製品別動向分析レポート、セグメント別予測、2025年～2030年

米国の血管アクセスデバイス市場動向

米国の血管アクセスデバイス市場規模は、2024年に14億米ドルと推定され、2025～2030年にかけてCAGR 5.6％で成長すると予測されています。

市場成長の原動力は、慢性疾患の有病率の増加と、血管アクセスを必要とする医療処置のニーズの高まりです。医療プロバイダーが薬剤、輸液、栄養剤を送達するための効率的なソリューションを求め続けているため、革新的な血管アクセスデバイスの需要が高まると予想されます。さらに、抗菌コーティングの開発や血管アクセス機器へのスマート技術の統合といった技術の進歩は、患者の安全性の向上と臨床転帰の改善に寄与しています。

米国におけるCVD患者の増加は、市場の成長を促進すると予想されます。2024年1月に発表された米国心臓協会の紙製によると、米国ではCVDにより毎日約2,552人が死亡しています。CVD患者は薬剤や輸液を含む長期的な治療を必要とし、多くの場合、中心静脈カテーテル（CVC）や末梢挿入型中心静脈カテーテル（PICC）のような血管アクセスデバイスを通して投与されます。これらの機器はCVDを効果的に管理する上で重要な役割を果たすため、心血管治療に対する需要の高まりが市場の主要な促進要因となっています。

米国の血管アクセスデバイス産業の成長は、小児患者の血管アクセスデバイス使用の増加によっても牽引されています。たとえば、人口問題ラボは2024年1月、米国の65歳以上の人口が2022年の5,800万人から2050年には8,200万人へと47％増加すると予測しています。さらに、この年齢層が総人口に占める割合は17％から23％に増加すると予測されていました。高齢者は感染症にかかりやすく、体力、エネルギー、水分補給を維持するための非経口栄養（PN）の投与による病院での治療が必要となります。

さらに、がん患者の増加と化学療法の需要が市場の成長を促進すると予想されています。米国国立がんラボによると、2024年には米国で新たに約200万1,140人のがん患者が診断され、推定61万1,720人がこの病気で死亡すると予測されています。がん治療、特に化学療法は、がんを管理する上で重要な役割を果たします。2023年3月に発表されたHealth Cost Instituteの記事によると、米国では毎年100万人近くが化学療法を受けています。これらの治療のほとんどは点滴や注射で行われ、しばしば患者は医師の診察室や病院の外来を訪れる必要があります。

がん治療における輸液療法の普及は、化学療法を実施する上で、末梢挿入型中心静脈カテーテル（PICC）や中心静脈カテーテル（CVC）などの血管アクセスデバイスの重要な役割を強調しています。治療中のがん患者の血流への安全で効果的かつ長期的なアクセスを確保するために、これらの器具が不可欠であるためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の血管アクセスデバイス市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国血管アクセスデバイス市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • パイプライン分析

第4章 米国の血管アクセスデバイス市場：製品別、推定・動向分析

• 米国の血管アクセスデバイス市場：製品ダッシュボード
• 米国の血管アクセスデバイス市場：製品変動分析
• 米国の血管アクセスデバイス市場（製品別、収益別）
• 中心静脈カテーテル（CVC）
  • トンネルCVC
  • 非トンネルCVC
• 末梢静脈栄養（PPN）
  • 高機能
  • 標準

第5章 競合情勢

• 主要メーカーによる最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店とチャネルパートナー一覧
  • 主要企業の市場シェア分析、2024年
• 企業プロファイル
  • BD
  • Teleflex
  • B Braun
  • Medical Components, Inc
  • Vygon SA
  • Medtronic/Mozarc Medical
  • Merit Medical/AngioDynamics
  • その他

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. vascular access devices market, by product, 2018 - 2030 (USD Billion)
• Table 3 Participant's overview
• Table 4 Financial performance
• Table 5 Key companies undergoing expansions
• Table 6 Key companies undergoing acquisitions
• Table 7 Key companies undergoing collaborations
• Table 8 Key companies launching new products
• Table 9 Key companies undergoing partnerships
• Table 10 Key companies undertaking other strategies

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 QFD modeling for market share assessment
• Fig. 6 Market formulation & validation
• Fig. 7 U.S. vascular access devices market: market outlook
• Fig. 8 U.S. vascular access devices competitive insights
• Fig. 9 Parent market outlook
• Fig. 10 Related/ancillary market outlook
• Fig. 11 Penetration and growth prospect mapping
• Fig. 12 U.S. vascular access devices market driver impact
• Fig. 13 U.S. vascular access devices market restraint impact
• Fig. 14 U.S. vascular access devices: Product movement analysis
• Fig. 15 U.S. vascular access devices: Product outlook and key takeaways
• Fig. 16 Central Venous Catheters (CVC) market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 17 Tunneled CVC market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 18 Non-Tunneled CVC market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 19 Peripherally Inserted Central Catheter (PICCs) market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 20 Power Injected market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 21 Standard market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 22 Key company categorization
• Fig. 23 Strategy mapping

U.S. Vascular Access Devices Market Trends:

The U.S. vascular access devices market size was estimated at USD 1.40 billion in 2024 and is expected to grow at a CAGR of 5.6% from 2025 to 2030. The market growth is driven by the increasing prevalence of chronic diseases and the growing need for medical procedures that require vascular access. As healthcare providers continue to seek efficient solutions for delivering medications, fluids, and nutrients, the demand for innovative vascular access devices is expected to rise. Additionally, advancements in technology, such as the development of antimicrobial coatings and the integration of smart technologies in vascular access devices, contribute to enhancing patient safety and improving clinical outcomes.

The rising CVD cases in the U.S. are expected to fuel the market growth. According to the American Heart Association article published in January 2024, in the U.S., CVD results in about 2,552 deaths each day. CVD patients require long-term treatments involving medications and fluids, often administered through vascular access devices like central venous catheters (CVCs) and peripherally inserted central catheters (PICCs). This growing demand for cardiovascular care is a key driver for the market, as these devices play a critical role in managing CVD effectively

The growth of the U.S. vascular access devices industry is also driven by rising use of vascular access devices among pediatric patients. For instance, in January 2024, the Population Reference Bureau had projected that the American population aged 65 and over would expand from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. Additionally, it was anticipated that the share of the total population belonging to this age bracket would grow from 17% to 23%. Older adults are easily susceptible to infectious diseases and need hospital treatment by administering parenteral nutrition (PN), which helps maintain strength, energy, and hydration.

In addition, increased cancer cases and chemotherapy demand is anticipated to drive the growth of the market. According to the National Cancer Institute, in 2024, it is projected that approximately 2,001,140 new cancer cases will be diagnosed in the United States, with an estimated 611,720 individuals expected to die from the disease. Cancer treatment, particularly chemotherapy, plays a crucial role in managing the condition. According to a Health Cost Institute article published in March 2023, nearly 1 million people in the U.S. undergo chemotherapy each year. Most of these treatments are administered via infusion or injection, often requiring patients to visit a physician's office or hospital outpatient department.

The widespread use of infusion therapies in cancer treatment underscores the critical role of vascular access devices, such as peripherally inserted central catheters (PICCs) and central venous catheters (CVCs), in delivering chemotherapy. This growing demand for oncology care is drives the North American vascular access devices market, as these devices are essential for ensuring safe, effective, and long-term access to the bloodstream for cancer patients undergoing treatment.

U.S. Vascular Access Devices Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. vascular access devices market report based on product:

• Product Outlook (Revenue, USD Billion, 2018 - 2030)
• Central Venous Catheters (CVC)
  • Tunneled CVC
  • Non-Tunneled CVC
• Peripherally Inserted Central Catheter (PICCs)
  • Power Injected
  • Standard

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Vascular Access Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing prevalence of cardiovascular diseases
    • 3.2.1.2. Increasing need for vascular access devices in oncology
    • 3.2.1.3. Technological advancements in vascular access devices
    • 3.2.1.4. Rising use of vascular access devices among pediatric patients
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations and product recalls
    • 3.2.2.2. Risks associated with catheter usage
• 3.3. U.S. Vascular Access Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pipeline Analysis

Chapter 4. U.S. Vascular Access Devices Market: Product Estimates & Trend Analysis

• 4.1. Global U.S. Vascular Access Devices Market: Product Dashboard
• 4.2. Global U.S. Vascular Access Devices Market: Product Movement Analysis
• 4.3. Global U.S. Vascular Access Devices Market by Product, Revenue
• 4.4. Central Venous Catheters (CVC)
  • 4.4.1. Central Venous Catheters (CVC) market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.2. Tunneled CVC
    • 4.4.2.1. Tunneled CVC market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.3. Non-Tunneled CVC
    • 4.4.3.1. Tunneled CV market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.5. Peripheral Parenteral Nutrition (PPN)
  • 4.5.1. Peripheral parenteral nutrition (PPN) market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5.2. Power Injected
    • 4.5.2.1. Power Injected market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5.3. Standard
    • 4.5.3.1. Standard market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

• 5.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 5.2. Company/Competition Categorization
• 5.3. Vendor Landscape
  • 5.3.1. List of key distributors and channel partners
  • 5.3.2. Key customers
  • 5.3.3. Key company market share analysis, 2024
• 5.4. Company Profiles
  • 5.4.1. BD
    • 5.4.1.1. Company overview
    • 5.4.1.2. Financial performance
    • 5.4.1.3. Product benchmarking
    • 5.4.1.4. Strategic initiatives
  • 5.4.2. Teleflex
    • 5.4.2.1. Company overview
    • 5.4.2.2. Financial performance
    • 5.4.2.3. Product benchmarking
    • 5.4.2.4. Strategic initiatives
  • 5.4.3. B Braun
    • 5.4.3.1. Company overview
    • 5.4.3.2. Financial performance
    • 5.4.3.3. Product benchmarking
    • 5.4.3.4. Strategic initiatives
  • 5.4.4. Medical Components, Inc
    • 5.4.4.1. Company overview
    • 5.4.4.2. Financial performance
    • 5.4.4.3. Product benchmarking
    • 5.4.4.4. Strategic initiatives
  • 5.4.5. Vygon SA
    • 5.4.5.1. Company overview
    • 5.4.5.2. Financial performance
    • 5.4.5.3. Product benchmarking
    • 5.4.5.4. Strategic initiatives
  • 5.4.6. Medtronic/Mozarc Medical
    • 5.4.6.1. Company overview
    • 5.4.6.2. Financial performance
    • 5.4.6.3. Product benchmarking
    • 5.4.6.4. Strategic initiatives
  • 5.4.7. Merit Medical/AngioDynamics
    • 5.4.7.1. Company overview
    • 5.4.7.2. Financial performance
    • 5.4.7.3. Product benchmarking
    • 5.4.7.4. Strategic initiatives
  • 5.4.8. Others
    • 5.4.8.1. Company overview
    • 5.4.8.2. Financial performance
    • 5.4.8.3. Product benchmarking
    • 5.4.8.4. Strategic initiatives